Repligen (RGEN) Fails to deliver data

Key failure to deliver metrics for Repligen :

• Last SEC data release: 2026-03-31
• Last 15 days FTD volume: £2.11 M
• Last 3 months FTD volume: £8.1 M
• Last 12 months FTD volume: £20.27 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Repligen (RGEN) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Repligen (RGEN) - since 2013

Repligen (RGEN) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Pfizer PFE	£23.8 M	£0.12 B	🇺🇸 USA
Thermo Fisher Scientific TMO	£4.93 M	£58.59 M	🇺🇸 USA
General Electric GE	£33.66 M	£0.24 B	🇺🇸 USA
Bristol-Myers Squibb BMY	£20.35 M	£70.85 M	🇺🇸 USA
Sangamo Therapeutics SGMO	£0.45 M	£8.18 M	🇺🇸 USA
Novavax NVAX	£12.4 M	£65.68 M	🇺🇸 USA
Neurocrine Biosciences NBIX	£3.75 M	£18.78 M	🇺🇸 USA
Bio-Techne TECH	£12.73 M	£30.64 M	🇺🇸 USA
BioMarin Pharmaceutical BMRN	£5 M	£17.4 M	🇺🇸 USA
Charles River Laboratories CRL	£17.99 M	£0.13 B	🇺🇸 USA